Searchable abstracts of presentations at key conferences in endocrinology

ea0089c1 | Clinical – Chemo/SSA/Biologics | NANETS2022

Progression-Free Survival in Patients with Bronchopulmonary Neuroendocrine Tumors Treated with Lanreotide or Placebo: Adjustment for Crossover Effects in Placebo Arm

Singh Simron , Buikhuisen Wieneke , Capdevila Jaume , Caplin Martyn E , Grohe Christian , Horsch Dieter , Raderer Markus , Reidy-Lagunes Diane , Wolin Edward M , Pommie Christelle , Mai Truong Xuan , Baudin Eric

Background: SPINET was a phase 3 trial (NCT02683941) in patients with well-differentiated, advanced bronchopulmonary neuroendocrine tumors (NETs; typical and atypical carcinoids [TCs and ACs]). During the double-blind (DB) period, patients were randomized (2:1) to receive lanreotide autogel/depot (LAN; 120 mg) or placebo (PBO) every 28 days; in the optional open-label (OL) phase, all patients received LAN. Recruitment was stopped early due to slow accrual; all eligible patient...

ea0090ep90 | Adrenal and Cardiovascular Endocrinology | ECE2023

Multifocal paraganglioma due to SDHB mutation: On purpose of one clinical case

Ferreira-Ocampo Pablo , Doejo Marciales Sandra Carolina , Barra Malig Solange Fabiola , Astunague Condori Remy Edward , Chicharro Pablo Lois , Ruiz Francisca Almodovar , Gorgojo Martinez Juan Jose , Salinas Helena Requejo

The mutations of succinate dehydrogenase subunits (SDHA, SDHB, SDHC, SDHD) are linked with a predisposition to develop pheochromocytoma and paraganglioma, often in diferent locations of the body. With greater acces to genetic tests, current estimations suggest that 40-50% of pheocromocytoma and paraganglioma cases are inherited and half of them are due to SDH mutations. These mutations can be associated with other tumours like renal carcinomas, gastrointestinal stroma tumours ...

ea0090ep961 | Thyroid | ECE2023

Alemtuzumab-Induced Autoimmune Thyroid Dysfunction. A review of two cases

Lois Chicharro Pablo , Miren Azcutia Uribe Echevarria Ane , Ferreira-Ocampo Pablo , Carolina Doejo Marciales Sandra , Fabiola Barra Malig Solange , Edward Astunague Condori Remy , Almodovar Ruiz Francisca

Introduction: Alemtuzumab is an humanized monoclonal antibody used for treatment of Relapsing remitting Multiple Sclerosis (RRMS). One of its main adverse effects is thyroid dysfunction, being a fluctuating hypothyroidism the most frequent presentation. Sometimes this thyroid disturbance is so significant that it might lead to alemtuzumab withdrawal. We present two Clinical cases of hyperthyroidism secondary to alemtuzumab with different clinical courses. <p class="abstext...

ea0049ep577 | Diabetes complications | ECE2017

Predictors of in-hospital mortality in diabetic patients – analysis of 958305 hospitalizations

Walicka Magdalena , Puzianowska-Kuznicka Monika , Chlebus Marcin , Sliwczynski Andrzej , Brzozowska Melania , Rutjowski Daniel , Kania Lidia , Czech Marcin , Jacyna Andrzej , Franek Edward

Background: Diabetes mellitus is a lifelong chronic disease with higher risk of mortality and morbidityObjective: To study the risk factors of death in hospitalized diabetic patientsMethods: Data obtained from the database of the National Health Fund (NHF), a public organization financing medical procedures in Poland regarded 958305 hospitalizations of adult (≥18 years old) patients with diabetes in 2014 year. Logistic regres...

ea0059p007 | Adrenal and steroids | SFEBES2018

Salivary cortisol determination using the Roche generation II assay

Spence Kirsty , McKeever Edward , Graham Una , Irwin Shirley , Neely Jeremy , McAlister Catherine , Courtney Hamish , Hunter Steven , Mullan Karen , McCance David , McDonnell Margaret

The Endocrine Society guidelines recommend initial testing for Cushing’s syndrome (CS) can be based on non-invasive late-night salivary cortisol measurement (NSC). In the BHSCT NSC (11pm), measured using the IBL ELISA kit has been found to be highly discriminative in identifying patients with CS. However it is a labour intensive test and the need for analysing samples in batches delays turnaround time, limiting its use in the routine work-up for CS. Roche provide an autom...

ea0034p398 | Thyroid | SFEBES2014

Neurocognitive and CNS abnormalities in humans with defective thyroid receptor α

Moran Carla , Visser Edward , Schoenmakers Nadia , Muntoni Francesco , Clark Chris , Gadian David , Chong Kling , Kuczynski Adam , Dattani Mehul , Vargha-Khadem Faraneh , Chatterjee Krishna

Background: The severe neurodevelopmental phenotype of untreated congenital hypothyroidism exemplifies the critical role of thyroid hormones (TH) in CNS development, acting via thyroid hormone receptor α1 (TRα1) on cortical neurogenesis, cerebellar development and oligodendrocyte differentiation. We have identified the first humans with defective TRα1 and investigated neurocognitive phenotype and CNS abnormalities in this disorder.Methods:...

ea0070aep1025 | Hot topics (including COVID-19) | ECE2020

Medications used by individuals with fibrodysplasia ossificans progressiva (FOP): Data from a global natural history study

C. Hsiao Edward , Al Mukaddam Mona , Baujat Geneviève , De Cunto Carmen , Keen Richard , J Pignolo Robert , Harnett Kathleen , Marino Rose , Kaplan Frederick S

Background: FOP is an ultra-rare genetic disorder characterised by episodic progressive heterotopic ossification (HO) and flare-ups, causing cumulative disability and early death. FOP is diagnosed and managed by multiple specialists, including endocrinologists. There are no established disease-modifying therapies to prevent HO in FOP. Treatment guidelines for symptomatic relief of FOP have recently been published by the International Clinical Council on FOP (ICC).1<...

ea0056p48 | Adrenal cortex (to include Cushing's) | ECE2018

Percutaneous microwave ablation of adrenal remnant tissue. A novel treatment modality for persistent Cushing’s disease

Ramli Rozana , Almazrouei Raya , Hameed Saira , Wernig Florian , Sam Amir , Leen Edward , Palazzo Fausto , Mendoza Nigel , Hatfield Emma , Martin Niamh , Meeran Karim

A 29-year-old lady presented with features of Cushing’s syndrome in October 2014. Investigations confirmed ACTH–dependent Cushing’s syndrome. An MRI scan showed a 4.5 mm right-sided pituitary lesion and subsequent inferior petrosal sinus sampling confirmed a central source of ACTH hypersecretion. She underwent trans-sphenoidal pituitary surgery in January 2015. Histology confirmed a corticotroph adenoma with a Ki-67 proliferation index of 1%. However, a mean cor...

ea0045oc5.8 | Oral Communications 5- Endocrine | BSPED2016

Understanding the Utility of Performing Endocrine & Genetic Investigations in Boys with a Suspected Disorder of Sex Development

Nixon Rachael , Cerqueira Vera , Kyriakou Andreas , Lucas-Herald Angela , McNeilly Jane , Diver Louise , Clelland Sharleene , Baird William , McMillan Martin , Purvis Andrew , Tobias Edward , McGowan Ruth , Ahmed Syed Faisal

Introduction: Evaluation of XY DSD requires a combination of endocrine and genetic tests. It is unclear whether these two sets of investigations should be performed stepwise or in parallel.Aims: The aim of the study was to document the range of endocrine and genetic abnormalities identified in all XY boys who were investigated at one specialist multidisciplinary service.Methods: Case records were reviewed to collect information fro...

ea0073aep710 | Thyroid | ECE2021

Thyroglobulin and thyroglobulin antibody measurements in the follow-up of differentiated thyroid cancer: practical implications for laboratories illustrated by means of a new highly sensitive thyroglobulin assay

Schoonen Lise , Neele Marjolein , van Toor Hans , van Kinschot Caroline , van Noord Charlotte , Visser Edward , Sjoerd van den Berg , Snježana Kos

IntroductionMeasurements of thyroglobulin (Tg) and Tg antibodies play a crucial role in the follow-up of treated differentiated thyroid cancer (DTC) patients, for instance to determine the response to therapy and the use of additional investigations and therapies. The aim of this study was to explore, from a laboratory perspective, the practical implications of the substantial clinical role of these measurements being imposed by national and internationa...